Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma

Leucine-rich repeat kinase 2 (LRRK2) is known to play a crucial role in the pathophysiology of neurodegenerative disorders such as Parkinson’s disease. LRRK2 is predominantly expressed in the lung as well as the brain. However, it is unclear whether LRRK2 expression correlates with the pathogenesis...

Full description

Bibliographic Details
Main Authors: Sung Won LEE, Sangwook PARK
Format: Article
Language:English
Published: The Korean Society for Clinical Laboratory Science 2023-06-01
Series:Korean Journal of Clinical Laboratory Science
Subjects:
Online Access:http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2023.55.2.105
_version_ 1797787196188524544
author Sung Won LEE
Sangwook PARK
author_facet Sung Won LEE
Sangwook PARK
author_sort Sung Won LEE
collection DOAJ
description Leucine-rich repeat kinase 2 (LRRK2) is known to play a crucial role in the pathophysiology of neurodegenerative disorders such as Parkinson’s disease. LRRK2 is predominantly expressed in the lung as well as the brain. However, it is unclear whether LRRK2 expression correlates with the pathogenesis of lung squamous cell carcinoma (LUSC). This study analyzes the prognostic significance of LRRK2 in LUSC using the Kaplan-Meier plotter tool. High expression of LRRK2 is known to be associated with a bad prognosis in patients with LUSC. Patients with high LRRK2 expression, tumor mutational burden, high neoantigen load, and even gender correlation reportedly have the worse survival rates. In the gene expression profiling interactive analysis (GEPIA) database, the severity of pathogenesis in LUSC with high LRRK2 expression positively corresponds to a high expression of anti-inflammatory cytokines but not inflammatory cytokines. Similarly, the increased expression of interleukin (IL)10-related genes was shown to be significantly linked in LRRK2-high LUSC patients having a poor prognosis. Moreover, the tumor immune estimation resource (TIMER) database suggests that macrophages are one of the cellular sources of IL10 in LRRK2-high LUSC patients. Collectively, our results demonstrate that the postulated LRRK2-IL10 axis is a potential therapeutic target and prognostic biomarker for LUSC.
first_indexed 2024-03-13T01:19:31Z
format Article
id doaj.art-75d3b3140ad7490cbef188234e9f5930
institution Directory Open Access Journal
issn 1738-3544
language English
last_indexed 2024-03-13T01:19:31Z
publishDate 2023-06-01
publisher The Korean Society for Clinical Laboratory Science
record_format Article
series Korean Journal of Clinical Laboratory Science
spelling doaj.art-75d3b3140ad7490cbef188234e9f59302023-07-05T05:27:51ZengThe Korean Society for Clinical Laboratory ScienceKorean Journal of Clinical Laboratory Science1738-35442023-06-0155210511210.15324/kjcls.2023.55.2.105kjcls.2023.55.2.105Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell CarcinomaSung Won LEE0Sangwook PARK1Department of Biomedical Laboratory Science, College of Health and Biomedical Services, Sangji University, Wonju, KoreaDepartment of Biomedical Laboratory Science, College of Health and Biomedical Services, Sangji University, Wonju, KoreaLeucine-rich repeat kinase 2 (LRRK2) is known to play a crucial role in the pathophysiology of neurodegenerative disorders such as Parkinson’s disease. LRRK2 is predominantly expressed in the lung as well as the brain. However, it is unclear whether LRRK2 expression correlates with the pathogenesis of lung squamous cell carcinoma (LUSC). This study analyzes the prognostic significance of LRRK2 in LUSC using the Kaplan-Meier plotter tool. High expression of LRRK2 is known to be associated with a bad prognosis in patients with LUSC. Patients with high LRRK2 expression, tumor mutational burden, high neoantigen load, and even gender correlation reportedly have the worse survival rates. In the gene expression profiling interactive analysis (GEPIA) database, the severity of pathogenesis in LUSC with high LRRK2 expression positively corresponds to a high expression of anti-inflammatory cytokines but not inflammatory cytokines. Similarly, the increased expression of interleukin (IL)10-related genes was shown to be significantly linked in LRRK2-high LUSC patients having a poor prognosis. Moreover, the tumor immune estimation resource (TIMER) database suggests that macrophages are one of the cellular sources of IL10 in LRRK2-high LUSC patients. Collectively, our results demonstrate that the postulated LRRK2-IL10 axis is a potential therapeutic target and prognostic biomarker for LUSC.http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2023.55.2.105anti-inflammatory cytokinesgene expression profiling interactive analysiskaplan-meierleucine-rich repeat kinase 2lung squamous cell carcinoma
spellingShingle Sung Won LEE
Sangwook PARK
Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
Korean Journal of Clinical Laboratory Science
anti-inflammatory cytokines
gene expression profiling interactive analysis
kaplan-meier
leucine-rich repeat kinase 2
lung squamous cell carcinoma
title Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
title_full Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
title_fullStr Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
title_full_unstemmed Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
title_short Correlation of Protumor Effects of Leucine-Rich Repeat Kinase 2 with Interleukin-10 Expression in Lung Squamous Cell Carcinoma
title_sort correlation of protumor effects of leucine rich repeat kinase 2 with interleukin 10 expression in lung squamous cell carcinoma
topic anti-inflammatory cytokines
gene expression profiling interactive analysis
kaplan-meier
leucine-rich repeat kinase 2
lung squamous cell carcinoma
url http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2023.55.2.105
work_keys_str_mv AT sungwonlee correlationofprotumoreffectsofleucinerichrepeatkinase2withinterleukin10expressioninlungsquamouscellcarcinoma
AT sangwookpark correlationofprotumoreffectsofleucinerichrepeatkinase2withinterleukin10expressioninlungsquamouscellcarcinoma